Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND & AIMS: Several meta-analyses have demonstrated the efficacy of psychological therapies for reducing gastrointestinal (GI) symptoms in patients with irritable bowel syndrome (IBS). However, no meta-analysis has investigated the duration of these effects. We performed a meta-analysis to assess the immediate, short-term, and long-term efficacy of psychotherapy for reducing GI symptoms in adults with IBS. METHODS: We searched PubMed, PsycINFO, Science Direct, and ProQuest Dissertations and Theses through August 15, 2015 for randomized controlled trials that compared psychological therapy with an active or non-active comparison (control) condition for treatment of GI symptoms in adults with IBS. RESULTS: Forty-one trials were included in our meta-analysis, comprising data from 2290 individuals (1183 assigned to psychotherapy and 1107 assigned to a control condition). Compared with a mixed group of control conditions, psychological therapies had a medium effect on GI symptom severity (d¯ = 0.69) immediately after treatment. On average, individuals who received psychotherapy had a greater reduction in GI symptoms after treatment than 75% of individuals assigned to a control condition. After short-term follow-up periods (1-6 months after treatment) and long-term follow-up periods (6-12 months after treatment), this effect remained significant and medium in magnitude (d¯ = 0.76 and d¯ = 0.73, respectively). CONCLUSIONS: Psychological therapies reduce GI symptoms in adults with IBS. These effects remained significant and medium in magnitude after short-term and long-term follow-up periods.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and meta-analysis found that psychological therapies produce a medium-sized reduction in GI symptoms in adults with IBS immediately after treatment, and these effects remain significant and medium-sized at short-term (1–6 months) and long-term (6–12 months) follow-up. The analysis included 41 RCTs and 2290 participants.
Key findings
- Across 41 trials (1183 psychotherapy, 1107 control), psychological therapies reduced GI symptom severity immediately after treatment versus mixed controls: d=0.69, P<.001, 95% CI 0.52–0.86; the average psychotherapy participant improved more than 75% of controls.
- Effects remained medium-sized at short-term follow-up (14 trials; d=0.76, P<.001, 95% CI 0.54–0.97) and long-term follow-up (10 trials; d=0.73, P<.001, 95% CI 0.43–1.03). In the 5 trials with all three intervals, effects were d=0.54 immediately, d=0.76 short-term, and d=0.73 long-term.
- No significant moderator effects were found for therapeutic modality (cognitive d=0.73, hypnosis d=0.78, relaxation d=0.72; Q=0.08, P=.960), delivery method (online vs in-person; Q=1.98, P=.160), format (group vs individual; Q=0.19, P=.666), dose, control type (active vs non-active; Q=0.01, P=.929), or publication date. Country differed: Sweden d=1.14 vs US d=0.54 and UK d=0.32.
- Attrition risk of bias moderated effects: high-risk studies showed d=−0.03 (P=.875), versus unclear d=0.83 and low d=0.73 (Q=13.15, P=.001). No significant publication bias was detected at immediate, short-term, or long-term follow-up by Egger and rank correlation tests.
Methods
- Systematic review and meta-analysis conducted per PRISMA with an a priori protocol. Searched PubMed, PsycINFO, ScienceDirect, and ProQuest Dissertations and Theses through August 15, 2015 for RCTs comparing psychological therapy with active or non-active control for GI symptoms in adults with IBS.
- Included 41 unique trials comprising 2290 individuals (1183 psychotherapy, 1107 control). Eligible trials assessed continuous GI symptom outcomes, were written in English, and excluded quasi-randomized allocation, support-group-only interventions, and dichotomous outcomes.
- Standardized mean differences (SMDs) were computed and pooled with random-effects weights using Comprehensive Meta-Analysis v3.3.070. Heterogeneity was assessed with Q, τ², and I²; risk of bias used the Cochrane tool; pre-specified moderator analyses examined therapy type, delivery, format, dose, control type, country, and publication date.
Limitations
- Stated: substantial between-trial variability in measures, inclusion criteria, and control conditions; effects may vary by individual patient characteristics, but this was impossible to assess because of inconsistent reporting and limited diversity (participants were mostly female and mostly white in trials reporting these data).
- Stated: no trial was rated low risk of bias in every domain; after excluding blinding, only 9 trials were low risk in all remaining domains. Few studies collected short-term or long-term follow-up data, and only 3 online therapy trials were included.
- Evident: heterogeneity was substantial (I²=70.56 immediate, 58.63 short-term, 74.86 long-term), and high attrition-bias studies showed no significant effect, which may limit confidence in pooled estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 17 cited sources checked · 0 supported · 0 flagged
- Findingown data
There was a significant effect of risk of bias in the domain of attrition (Q=13.15, P=.001).
“There was a significant effect of risk of bias in the domain of attrition (Q ¼ 13.15, P ¼ .001).”
Quote in the paperSubstantial claim - Findingcitation
In 2 of these trials, the treatment group improved more than the control group on a dichotomous outcome measure identified by the authors as the primary outcome.
“In 2 of these trials, the treatment group improved more than the control group on a dichotomous outcome measure identified by the authors as the primary outcome.57,59”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Shinozaki, 2010, Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial, Appl Psychophysiol Biofeedback source
Not checked in the free run.
- cites [59] Tkachuk, 2003, Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting, Journal of Clinical Psychology in Medical Settings source
Not checked in the free run.
- Findingown data
There was significant heterogeneity among studies at this time point (Q=35.80, P<.001, tau^2=0.17, I^2=74.86).
“(d ¼ 0.73, P < .001;95% CI, 0.43-1.03;Q ¼ 35.80,P < .001,s 2 ¼ 0.17, I 2 ¼ 74.86).”
Quote in the paperNot a substantial claim - Findingown data
Within therapies administered in person, there was no significant difference in effect between group and individual format.
“Within therapies administered in person, there was no significant difference in the effect of interventions administered in a group (d ¼ 0.56, P ¼ .004;95% CI, 0.18-0.94)vs individual format (d ¼ 0.66, P < .001;95% CI, 0.47-0.84;Q ¼ 0.19, P ¼ .666).”
Quote in the paperNot a substantial claim - Findingown data
There was no evidence of significant publication bias at the first post-treatment follow-up.
“There was no evidence of significant publication bias at the first post-treatment follow-up, as indicated by the Egger test (b ¼ 0.57, P ¼ .583)and the rank correlation test (s ¼ 0.09, P ¼ .439).”
Quote in the paperNot a substantial claim
- Findingown data
There was a medium effect of psychotherapy on GI symptoms at short-term follow-up compared with mixed control conditions (d=0.76, P<.001; 95% CI 0.54-0.97).
“There was a medium effect of psychotherapy on GI symptoms at short-term follow-up compared with mixed control conditions (d ¼ 0.76, P < .001;95% CI, 0.54-0.97;Q ¼ 31.43,P ¼ .003,s 2 ¼ .10,I 2 ¼ 58.63).”
Quote in the paperSubstantial claim - Findingown data
At the first post-treatment assessment, psychological therapies had a mean effect on GI symptoms compared with mixed control conditions of d=0.73 (95% CI 0.43-1.03, P<.001).
“Figure 2 . Figure 2. Mean effects of psychological therapies on GI symptoms compared with mixed group of control conditions at the first post-treatment assessment.”
- Also stated in: § Selective Reporting · plain
“(d ¼ 0.73, P < .001;95% CI, 0.43-1.03;Q ¼ 35.80,P < .001,s 2 ¼ 0.17, I 2 ¼ 74.86).”
Quote in the paperSubstantial claim - Also stated in: § Selective Reporting · plain
- Findingown data
Effect sizes were significantly larger in Sweden than in the United Kingdom.
“and the United Kingdom (d ¼ 0.32, P ¼ .014;95% CI, 0.06-0.58;Q ¼ 8.84, P ¼ .003).”
Quote in the paperNot a substantial claim - Findingown data
Only 3 trials included in the meta-analysis assessed healthcare utilization as an outcome.
“These results are encouraging, but only 3 trials included in our meta-analysis assessed healthcare utilization as an outcome.”
Quote in the paperNot a substantial claim - Findingown data
There was no statistically significant difference between effect sizes of interventions delivered online versus in-person.
“There was no statistically significant difference between the effect sizes of interventions delivered online (d ¼ 1.33, P ¼ .006;95% CI, 0.38-2.27)vs in-person ðd ¼ 0.64, P < .001;95% CI, 0.47-0.80;Q ¼ 1.98, P ¼ .160).”
Quote in the paperNot a substantial claim - Findingown data
Compared with a mixed group of active and nonactive control conditions, psychological therapies were effective at improving GI symptoms immediately after treatment (d=0.69, P<.001; 95% CI 0.52-0.86).
“Compared with a mixed group of (active and nonactive) control conditions, psychological therapies were effective at improving GI symptoms (d ¼ 0.69, P < .001;95% CI, 0.52-0.86;Q ¼ 129.07, P < .001,s 2 ¼ 0.19, I 2 ¼ 70.56) immediately after treatment.”
Quote in the paperSubstantial claim - Findingnone given
There was substantial between-trial variability in many trial characteristics, such as measures used, inclusion criteria, and control conditions.
“First, there was substantial between-trial variability in many trial characteristics (eg, measures used, inclusion criteria, control conditions).”
Quote in the paperSubstantial claim - Findingcitation
Three trials provided effect sizes indicating greater improvement in the control group.
“Three trials provided effect sizes indicating greater improvement in the control group.56,57,59”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [56] Shahabi, 2016, Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study, Psychology, Health & Medicine source
Not checked in the free run.
- cites [57] Shinozaki, 2010, Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial, Appl Psychophysiol Biofeedback source
Not checked in the free run.
- cites [59] Tkachuk, 2003, Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting, Journal of Clinical Psychology in Medical Settings source
Not checked in the free run.
- Findingnone given
Of the 41 trials, 20 had not been included in the most recent meta-analysis evaluating the efficacy of psychological therapies on GI symptoms.
“Of the 41 trials, 20 had not been included in the most recent meta-analysis evaluating the efficacy of psychological therapies on GI symptoms.”
Quote in the paperNot a substantial claim - Findingown data
Cognitive, hypnosis, and relaxation therapies had similar effect sizes.
“These 3 modalities had similar effect sizes (cognitive: d ¼ 0.73, P < .001;95% CI, 0.48-0.97;hypnosis: d ¼ 0.78, P < .001;95% CI, 0.46-1.11;relaxation: d ¼ 0.72, P ¼ .050;95% CI, 0.00-1.43;Q ¼ 0.08, P ¼ .960).”
Quote in the paperSubstantial claim - Findingown data
There was a medium-sized effect of psychotherapy on GI symptoms at long-term follow-up.
“There was a medium-sized effect of psychotherapy on GI symptoms at long-term follow-up”
Quote in the paperSubstantial claim - Findingown data
Forty-one unique trials were determined eligible for the meta-analysis.
“Of the 1162 records identified through our search, 41 unique trials 19, were determined eligible for our meta-analysis.”
Quote in the paperSubstantial claim - Findingown data
Even after excluding the blinding domain, only 9 trials were rated as low risk of bias in all remaining domains.
“However, even after excluding this domain, only 9 trials were rated as low risk of bias in all remaining domains.”
Quote in the paperNot a substantial claim - Findingown data
No trial included in the meta-analysis was rated as low risk of bias in every domain.
“Another limitation is that no trial included in the meta-analysis was rated as low risk of bias in every domain.”
Quote in the paperNot a substantial claim - Findingown data
Effect sizes were similar for trials that used an active versus non-active control.
“Effect sizes were similar for trials that used an active ðd ¼ 0.66, P < .001;95% CI, 0.42-0.90)vs non-active control (d ¼ 0.68, P < .001;95% CI, 0.48-0.87)(Q ¼ 0.01, P ¼ .929).”
Quote in the paperNot a substantial claim - Findingown data
There was no evidence of significant publication bias at this time point, as indicated by the Egger test (b=5.09, P=.193) and the rank correlation test (s<0.18, P=.474).
“There was no evidence of significant publication bias at this time point, as indicated by the Egger test (b ¼ 5.09, P ¼ .193)and the rank correlation test (s < 0.18, P ¼ .474).”
Quote in the paperNot a substantial claim - Findingown data
Five studies included data for all three follow-up intervals.
“Figure 3 . Figure 3. Mean effects of psychological therapies on GI symptoms compared with control conditions for the 5 studies that included data for all 3 follow-up intervals by follow-up interval.”
Quote in the paperNot a substantial claim - Interpretationown data
In the 5 studies that provided data at all 3 follow-up intervals, effects were greater at short-term and long-term follow-up compared with immediately after treatment.
“In the 5 studies that provided data at all 3 follow-up intervals, effects were actually greater at short-term (d ¼ 0.76) and long-term follow-up (d ¼ 0.73) compared with immediately after treatment (d ¼ 0.54).”
Quote in the paperNot a substantial claim - Interpretationown data
Cognitive, relaxation, and hypnosis therapies may be equally effective at improving GI symptoms.
“The results suggest these 3 therapies may be equally effective at improving GI symptoms.”
Quote in the paperSubstantial claim - Study design and conductcitation
All included data were self-reported except one.
“We did not code risk of bias because of lack of blinding of outcome assessors separately from bias because of blinding of participants because, with one exception, all included data were selfreported.36”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Fernández, 1998, Stress and contingency management in the treatment of irritable bowel syndrome, Stress Med source
Not checked in the free run.
- Premisecitation
One RCT found that mean annual direct healthcare costs were significantly lower after 3 months of psychotherapy, but not 3 months of paroxetine, compared with TAU.
“One RCT investigating this question found that mean annual direct healthcare costs were significantly lower after 3 months of psychotherapy, but not 3 months of paroxetine, compared with TAU.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Creed, 2003, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome, Gastroenterology source
Not checked in the free run.
- Interpretationown data
The effect of psychotherapy on GI symptoms does not decrease during the course of a 6-month to 12-month follow-up interval.
“This remained true when using data only from studies with more than 1 follow-up, suggesting that the effect of psychotherapy on GI symptoms does not decrease during the course of a 6-month to 12-month follow-up interval.”
Quote in the paperSubstantial claim - Interpretationown data
The average individual assigned to psychotherapy experienced a greater decrease in GI symptoms than 75% of individuals assigned to a control condition.
“Transforming our post-treatment effect size to the U3 Index of Smith and Glass 64 indicated that the average individual assigned to psychotherapy experienced a greater decrease in GI symptoms than 75% of individuals assigned to a control condition.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Smith and Glass 64
Not checked in the free run.
- Premisecitation
A higher percentage of individuals who received psychotherapy discontinued their disability benefits during the trial (14.3%) compared with those who received paroxetine (3.6%) or TAU (4.1%).
“Furthermore, a higher percentage of individuals who received psychotherapy discontinued their disability benefits during the course of the trial (14.3%) compared with those who received paroxetine (3.6%) or TAU (4.1%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Creed, 2003, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome, Gastroenterology source
Not checked in the free run.
- May combine two claims. 12
- Classified as probably not a substantial claim. 14
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataThe majority of studies used interventions that combined several different treatment modalities, making it difficult to sort studies into discrete categories.
“However, the majority of studies used interventions that combined several different treatment modalities, making it difficult to sort studies into discrete categories.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIt was impossible to assess variation by individual patient characteristics because of inconsistent reporting and limited diversity, with participants mostly female and mostly white in trials that reported these data.
“Unfortunately, this was impossible to assess in the current metaanalysis because of inconsistent reporting and limited diversity (participants were mostly female and mostly white in trials that reported these data).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe numbers of trials meeting low risk of bias criteria for allocation sequence, concealment, blinding, incomplete outcome data, and selective reporting were 21, 16, 1, 22, and 34, respectively.
“The numbers of trials meeting criteria for low risk of bias that was due to (1) allocation sequence, (2) concealment of allocation sequence, (3) blinding, (4) incomplete outcome data, and (5) selective reporting were 21, 16, 1, 22, and 34, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNumber of sessions, average session duration, therapy duration, and session frequency were not significantly correlated with effect size.
“Number of sessions (b ¼ -0.02, P ¼ .527),average session duration (b < 0.01, P ¼ .491),therapy duration (b ¼ 0.01, P ¼ .886),and session frequency (b ¼ -0.04, P ¼.887) were not significantly correlated with effect size.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenFew studies collected short-term or long-term follow-up data.
“Finally, few studies collected short-term or long-term follow-up data.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 41 trials comprised data from 2290 individuals, with 1183 assigned to psychotherapy and 1107 assigned to a control condition.
“Forty-one trials were included in our meta-analysis, comprising data from 2290 individuals (1183 assigned to psychotherapy and 1107 assigned to a control condition).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataFor the 5 studies that included data for all three follow-up intervals, psychological therapies had mean effects on GI symptoms compared with control conditions at each follow-up interval.
“Figure 3 . Figure 3. Mean effects of psychological therapies on GI symptoms compared with control conditions for the 5 studies that included data for all 3 follow-up intervals by follow-up interval.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent meta-analysis of psychotherapy for depression found that number of treatment sessions was not significantly associated with effect size after controlling for other relevant study variables.
“These results are comparable to findings from a recent meta-analysis of the efficacy of psychotherapy for depression, 65 in which number of treatment sessions was not significantly associated with effect size after controlling for other relevant study variables.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Cuijpers, 2013, How much psychotherapy is needed to treat depression? a metaregression analysis, J Affect Disord source
Not checked in the free run.
May combine two claims.
PremisecitationPsychological therapies are as effective as antidepressants in reducing GI symptoms in IBS immediately after treatment, with a number needed to treat between 2 and 4.
“Meta-analyses suggest that psychological therapies are as effective as antidepressants in reducing GI symptoms in IBS immediately after treatment, with a number needed to treat between 2 and 4. [5][6][7]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Ford, 2014, Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis, Am J Gastroenterol source
Not checked in the free run.
- cites [6] Ford, 2009, Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis, Gut source
Not checked in the free run.
- cites [7] Lackner, 2004, Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis, J Consult Clin Psychol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe results were similar to a recently published meta-analysis that used binary outcome data to compare psychotherapy versus antidepressant medications for reducing GI symptoms in IBS.
“Our results were similar to a recently published metaanalysis that used binary outcome data to compare the efficacy of psychotherapy vs antidepressant medications for reducing GI symptoms in IBS.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Ford, 2014, Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis, Am J Gastroenterol source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe average post-treatment effect on GI symptoms in this analysis (d=0.69) was similar to that previously reported for bowel dysfunction (d=0.57) and considerably higher than that previously reported for abdominal pain (d=0.27).
“The average effect on GI symptoms after treatment (d ¼ 0.69) in our analysis was similar to that reported previously for bowel dysfunction (d ¼ 0.57) and considerably higher than that reported previously for abdominal pain (d ¼ 0.27) in the only previously published meta-analysis on this topic using continuous outcomes.7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Lackner, 2004, Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis, J Consult Clin Psychol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe remaining trial used walking as a comparison condition, which could arguably be conceptualized as an active treatment rather than a control condition.
“The remaining trial 56 used walking as a comparison condition, which could arguably be conceptualized as an active treatment rather than a control condition.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Shahabi, 2016, Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study, Psychology, Health & Medicine source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenSeveral meta-analyses have demonstrated the efficacy of psychological therapies for reducing GI symptoms in patients with IBS.
“Several meta-analyses have demonstrated the efficacy of psychological therapies for reducing gastrointestinal (GI) symptoms in patients with irritable bowel syndrome (IBS).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenBecause of the nature of psychotherapy, it is impossible for patients to be blinded to intervention content.
“Because of the nature of psychotherapy, it is impossible for patients to be blinded to intervention content.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe meta-analysis was conducted in accordance with the PRISMA statement and followed an a priori established protocol.
“This meta-analysis was conducted in accordance with the PRISMA statement and followed an a priori established protocol.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Cochrane Collaboration risk of bias assessment tool for RCTs was used to assess possible sources of bias in included trials.
“The risk of bias assessment tool developed by the Cochrane Collaboration 22 for RCTs was used to assess the following possible sources of bias in included trials”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Higgins J, Altman D. Assessing risk of bias in included studies. In: Higgins J, Green S, eds. The Cochrane Collaboration: Cochrane handbook for systematic reviews of interventions. Version 5.0.1. 2008. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAssessment of eligibility and data extraction were each performed independently by 2 authors.
“Assessment of eligibility and data extraction were each performed independently by 2 authors, and ITT data were used wherever possible.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataGroup format may be an effective and economical method of delivering psychological therapies to adults with IBS.
“Thus, group format may be an effective and economical method of delivering psychological therapies to adults with IBS.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenITT data were used wherever possible.
“ITT data were used wherever possible.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenIn this systematic review, L.S.W. and S.D.H. were consulted in unclear cases during screening, and disagreement was resolved through discussion.
“L.S.W. and S.D.H. were consulted in unclear cases; disagreement was resolved through discussion.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIn this systematic review, the authors were aware of the names of the study authors, results, and other publication information during the review process.
“Authors were aware of the names of the study authors, results, and other publication information.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataIn this systematic review, effect size data were entered by the first author (K.T.L.) and checked by another author (A.C.R.).
“Effect size data were entered by the first author (K.T.L.) and checked by another (A.C.R.).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn this systematic review, a single reviewer (K.T.L.) coded all variables other than effect size data.
“A single reviewer (K.T.L.) coded all other variables.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
No meta-analysis has investigated the duration of the effects of psychological therapies on GI symptoms in IBS.
“However, no meta-analysis has investigated the duration of these effects.”
The authors state this as an assumption.
Dichotomous outcome measures measure a different underlying construct than continuous measures.
“Dichotomous outcome measures were ineligible because these were assumed to measure a different underlying construct than continuous measures.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Our study demonstrated that CBT via telephone appeared to be the most beneficial in the long-term.
“In addition, although previous reviews have demonstrated the short and long-term efficacy of psychological therapies for IBS, [98] regardless of delivery method (in person or online), our study demonstrated that CBT via telephone appeared to be the most beneficial in the long-term.”
From Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis (2020) · cites this paper as [98]
The same two reviewers independently appraised study quality using the ASHA level of evidence scheme.
“The same two reviewers independently appraised included studies’ quality using indicators identified by the American Speech-Language Hearing Association (ASHA) level of evidence scheme.29,30”
From Benchmarks of Significant Change After Aphasia Rehabilitation (2019) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Eligibility was not independently assessed by two authors
MajorThe discussion says two authors independently assessed eligibility, but the methods say the first author assessed articles and consulted others only in unclear cases.
“Assessment of eligibility and data extraction were each performed independently by 2 authors”
“The first author (K.T.L.) screened titles/abstracts for relevance and evaluated all potentially relevant articles in detail to determine eligibility.L.S.W. and S.D.H. were consulted in unclear cases; disagreement was resolved through discussion.”
Svedlund's attrition rating conflicts with the stated rule
MinorThe stated rule requires ITT data for a low attrition-risk rating, but Table 2 marks Svedlund as not providing ITT data and nevertheless rates attrition risk low.
“| Svedlund | | Unclear | Unclear | (High) | 1.98 | N | Low | Low |”
“Studies providing ITT data and that had a participant dropout rate of 20% or less at the first post-treatment follow-up were coded as having a low risk of bias because of handling of incomplete outcome data.”
Data extraction was not independently performed by two authors
MinorThe discussion describes independent extraction by two authors. The methods instead describe one author entering effect-size data for another to check, while a single reviewer coded all other variables.
“Assessment of eligibility and data extraction were each performed independently by 2 authors”
“Effect size data were entered by the first author (K.T.L.) and checked by another (A.C.R.).A single reviewer (K.T.L.) coded all other variables.”
Cites
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,406 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371 · see citing works
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · see citing works
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · see citing works
Meta-analysis of psychotherapy outcome studies.
Smith, M. L., & Glass, G. V. (1977) · American Psychologist · doi:10.1037/0003-066x.32.9.752 · Cited by 2,154 · see citing works
The epidemiology of irritable bowel syndrome
Card, T., Canavan, C., & West, J. (2014) · Clinical Epidemiology · doi:10.2147/clep.s40245 · Cited by 889 · see citing works
Statistical power analysis for the behavioral sciences
Sockloff, A. L. (1978) · Evaluation and Program Planning · doi:10.1016/0149-7189(78)90080-0 · Cited by 715 · see citing works
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.015 · Cited by 604 · see citing works
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582 · see citing works
CONTROLLED TRIAL OF HYPNOTHERAPY IN THE TREATMENT OF SEVERE REFRACTORY IRRITABLE-BOWEL SYNDROME
Whorwell, P. J., Prior, A., & Faragher, E. B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92793-4 · Cited by 537 · see citing works
A controlled trial of psychological treatment for the irritable bowel syndrome
Guthrie, E., Creed, F. H., Dawson, D., & Tomenson, B. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90215-7 · Cited by 461 · see citing works
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
Creed, F., Fernandes, L., Guthrie, E., Palmer, S., Ratcliffe, J., Read, N., Rigby, C., Thompson, D., & Tomenson, B. (2003) · Gastroenterology · doi:10.1053/gast.2003.50055 · Cited by 443 · see citing works
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405 · see citing works
Schure, M. B., Christopher, J. C., & Christopher, S. E. (2008) · Journal of Counseling & Development · doi:10.1002/j.1556-6678.2008.tb00625.x · Cited by 322 · see citing works
Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis
Lackner, J. M., Mesmer, C., Morley, S., Dowzer, C., & Hamilton, S. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.6.1100 · Cited by 295 · see citing works
Gaylord, S. A., Palsson, O. S., Garland, E. L., Faurot, K. R., Coble, R. S., Mann, D. J., Frey, W., Leniek, K., & Whitehead, W. E. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.184 · Cited by 281 · see citing works
Ljótsson, B., Falk, L., Vesterlund, A. W., Hedman, E., Lindfors, P., Rück, C., Hursti, T., Andréewitch, S., Jansson, L., Lindefors, N., et al. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.003 · Cited by 270 · see citing works
How much psychotherapy is needed to treat depression? A metaregression analysis
Cuijpers, P., Huibers, M., Daniel Ebert, D., Koole, S. L., & Andersson, G. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.030 · Cited by 258 · see citing works
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243 · see citing works
Palsson, O. S., Turner, M. J., Johnson, D. A., Burnett, C. K., & Whitehead, W. E. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020545017390 · Cited by 195 · see citing works
The economic impact of irritable bowel syndrome
Inadomi, J. M., Fennerty, M. B., & Bjorkman, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.t01-1-01736.x · Cited by 190 · see citing works
Cognitive therapy for irritable bowel syndrome.
Greene, B., & Blanchard, E. B. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.3.576 · Cited by 188 · see citing works
Moss-Morris, R., McAlpine, L., Didsbury, L. P., & Spence, M. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709990195 · Cited by 187 · see citing works
Payne, A., & Blanchard, E. B. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.5.779 · Cited by 186 · see citing works
Zernicke, K. A., Campbell, T. S., Blustein, P. K., Fung, T. S., Johnson, J. A., Bacon, S. L., & Carlson, L. E. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9241-6 · Cited by 178 · see citing works
Lackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Holroyd, K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.004 · Cited by 176 · see citing works
Heymann-Monnikes, I., Arnold, R., Florin, I., Herda, C., Melfsen, S., & Monnikes, H. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01937.x · Cited by 169 · see citing works
Boyce, P. M., Talley, N. J., Balaam, B., Koloski, N. A., & Truman, G. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07716.x · Cited by 167 · see citing works
Payne, A., & Blanchard, E. B. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.5.779 · Cited by 166 · see citing works
Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome
Blanchard, E. B., Schwarz, S. P., Suls, J. M., Gerardi, M. A., Scharff, L., Greene, B., Taylor, A. E., Berreman, C. F., & Malamood, H. S. (1992) · Behaviour Research and Therapy · doi:10.1016/0005-7967(92)90141-3 · Cited by 148 · see citing works
The treatment of irritable bowel syndrome with hypnotherapy
Galovski, T. E., & Blanchard, E. B. (1998) · Applied Psychophysiology and Biofeedback · doi:10.1023/a:1022209631047 · Cited by 147 · see citing works
Relaxation training as a treatment for irritable bowel syndrome
Blanchard, E. B., Greene, B., Scharff, L., & Schwarz, S. P. (1993) · Applied Psychophysiology and Biofeedback · doi:10.1007/bf00999789 · Cited by 142 · see citing works
Cognitive therapy for irritable bowel syndrome.
Greene, B., & Blanchard, E. B. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.3.576 · Cited by 140 · see citing works
Brief cognitive-behavioral internet therapy for irritable bowel syndrome
Hunt, M. G., Moshier, S., & Milonova, M. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.05.002 · Cited by 139 · see citing works
Moser, G., Trägner, S., Gajowniczek, E. E., Mikulits, A., Michalski, M., Kazemi-Shirazi, L., Kulnigg-Dabsch, S., Führer, M., Ponocny-Seliger, E., Dejaco, C., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.19 · Cited by 139 · see citing works
Lindfors, P., Unge, P., Arvidsson, P., Nyhlin, H., Björnsson, E., Abrahamsson, H., & Simrén, M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.340 · Cited by 138 · see citing works
Ljótsson, B., Andersson, G., Andersson, E., Hedman, E., Lindfors, P., Andréewitch, S., Rück, C., & Lindefors, N. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-110 · Cited by 132 · see citing works
Taneja, I., Deepak, K. K., Poojary, G., Acharya, I. N., Pandey, R. M., & Sharma, M. (2004) · Applied Psychophysiology and Biofeedback · doi:10.1023/b:apbi.0000017861.60439.95 · Cited by 129 · see citing works
Cognitive-Behavioral Group Therapy for Irritable Bowel Syndrome
van Dulmen, S., Fennis, J. F. M., & Bleijenberg, G. (1996) · Psychosomatic Medicine · doi:10.1097/00006842-199609000-00013 · Cited by 122 · see citing works
A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome
Blanchard, E. B., Lackner, J. M., Sanders, K., Krasner, S., Keefer, L., Payne, A., Gudleski, G. D., Katz, L., Rowell, D., Sykes, M., et al. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.003 · Cited by 121 · see citing works
Lowén, M. B. O., Mayer, E. A., Sjöberg, M., Tillisch, K., Naliboff, B., Labus, J., Lundberg, P., Ström, M., Engström, M., & Walter, S. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12319 · Cited by 121 · see citing works
A multi-component treatment for irritable bowel syndrome
Neff, D. F., & Blanchard, E. B. (1987) · Behavior Therapy · doi:10.1016/s0005-7894(87)80052-7 · Cited by 119 · see citing works
Self-management for women with irritable bowel syndrome
Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., Barney, P., & Weisman, P. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00242-3 · Cited by 119 · see citing works
Quality of Life in Irritable Bowel Syndrome
Lea, R., & Whorwell, P. J. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119060-00003 · Cited by 106 · see citing works
Keefer, L., & Blanchard, E. B. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00078-4 · Cited by 104 · see citing works
Psychotherapy in Irritable Bowel Syndrome
Svedlund, J. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb03707.x · Cited by 86 · see citing works
(2006) · Europe PMC (PubMed Central) · Cited by 78 · see citing works
Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome
Vollmer, A., & Blanchard, E. B. (1998) · Behavior Therapy · doi:10.1016/s0005-7894(98)80016-6 · Cited by 68 · see citing works
Shinozaki, M., Kanazawa, M., Kano, M., Endo, Y., Nakaya, N., Hongo, M., & Fukudo, S. (2010) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-009-9125-y · Cited by 67 · see citing works
Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs
Oerlemans, S., van Cranenburgh, O., Herremans, P.-J., Spreeuwenberg, P., & van Dulmen, S. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.09.018 · Cited by 67 · see citing works
Behavioural psychotherapy in the treatment of irritable bowel syndrome
Corney, R., Stanton, R., Newell, R., Clare, A. W., & Fairclough, P. D. (1991) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(91)90041-l · Cited by 66 · see citing works
Labus, J., Gupta, A., Gill, H. K., Posserud, I., Mayer, M., Raeen, H., Bolus, R., Simren, M., Naliboff, B. D., & Mayer, E. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12171 · Cited by 64 · see citing works
Tkachuk, G. A., Graff, L. A., Martin, G. L., & Bernstein, C. N. (2003) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/a:1022809914863 · Cited by 62 · see citing works
Clinical trial: short‐ and long‐term benefit of relaxation training for irritable bowel syndrome
van der Veek, P. P. J., van Rood, Y. R., & Masclee, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03437.x · Cited by 59 · see citing works
Shahabi, L., Naliboff, B. D., & Shapiro, D. (2016) · Psychology, Health & Medicine · doi:10.1080/13548506.2015.1051557 · Cited by 59 · see citing works
Lahmann, C., Röhricht, F., Sauer, N., Noll‐Hussong, M., Ronel, J., Henrich, G., von Arnim, A., & Loew, T. H. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0084 · Cited by 46 · see citing works
Sanders, K. A., Blanchard, E. B., & Sykes, M. A. (2007) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-007-9037-7 · Cited by 43 · see citing works
Irritable bowel syndrome treatment: Cognitive behavioral therapy versus medical treatment
Mahvi-Shirazi, M., Fathi-Ashtiani, A., Rasoolzade-Tabatabaei, S.-K., & Amini, M. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.27292 · Cited by 40 · see citing works
A collaborative health care model for the treatment of irritable bowel syndrome
Gerson, C. D., & Gerson, M. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00218-0 · Cited by 29 · see citing works
Farnam, A., Somi, M. H., Farhang, S., Mahdavi, N., & Beshārat, M. A. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000442934.38704.3a · Cited by 25 · see citing works
Jang, A. L., Hwang, S.-K., & Kim, D. U. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000140 · Cited by 25 · see citing works
Deechakawan, W., Cain, K. C., Jarrett, M. E., Burr, R. L., & Heitkemper, M. M. (2013) · Biological Research For Nursing · doi:10.1177/1099800411414047 · Cited by 20 · see citing works
Boltin, D., Sahar, N., Gil, E., Aizic, S., Hod, K., Levi-Drummer, R., Niv, Y., & Dickman, R. (2015) · Journal of Health Psychology · doi:10.1177/1359105315573450 · Cited by 15 · see citing works
Classification and diagnosis of depression
Malt, U. F. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb00356.x · Cited by 13 · see citing works
Efficacy of training in stress and contingency management in cases of irritable bowel syndrome
Fernández, C., & Vázquez, I. A. (2006) · Stress and Health · doi:10.1002/smi.1106 · Cited by 10 · see citing works
Psychosomatic complaints and unwinding of sympathoadrenal activation after work
Fernández (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1700(199801)14:1
Flagged first, then by citations
Research works printed but not linked: 2
- Siegel KM. The effects of emotional disclosure on physical symptoms, healthcare utilization, and psychosocial adjustment in patients with irritable bowel syndrome. PhD dissertation. Alliant International University, San Diego, CA, 2003.
- Ljotsson, 2011, Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial, BMC Gastroenterol, 11, 110, 10.1186/1471-230x-11-110 · DOI · Paper page
Cited by
Sorted by citations
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893 · see citing works
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302 · see citing works
Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · Gut · doi:10.1136/gutjnl-2020-321191 · Cited by 299 · see citing works
“The primary outcome assessed was the efficacy of all psychological therapies and control interventions in IBS, in terms of effect on global IBS symptoms or abdominal pain after completion of therapy.”
InfluentialA Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213 · see citing works
Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.063 · Cited by 191 · see citing works
Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome
Chey, W. D., Keefer, L., Whelan, K., & Gibson, P. R. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.06.099 · Cited by 154 · see citing works
Laird, K. T., Tanner-Smith, E., Russell, A. C., Hollon, S., & Walker, L. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.001 · Cited by 140 · see citing works
Self-citationNew treatments and therapeutic targets for IBS and other functional bowel disorders
Simrén, M., & Tack, J. (2018) · Nature reviews: Gastroenterology & hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 127 · see citing works
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135 · see citing works
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117 · see citing works
Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights
Kinsinger, S. W. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s120817 · Cited by 119 · see citing works
Second Asian Consensus on Irritable Bowel Syndrome
Gwee, K., Gonlachanvit, S., Ghoshal, U. C., Chua, A. S. B., Miwa, H., Wu, J. C. Y., Bak, Y., Lee, O. Y., Lu, C., Park, H., et al. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19041 · Cited by 112 · see citing works
Roenneberg, C., Sattel, H., Schaefert, R., Henningsen, P., & Hausteiner-Wiehle, C. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0553 · Cited by 111 · see citing works
Hunt, M. G., Miguez, S. M., Dukas, B., Onwude, O., & White, S. J. (2021) · JMIR mhealth and uhealth · doi:10.2196/26152 · Cited by 98 · see citing works
Anxiety disorders and medical comorbidity: Treatment implications
Meuret, A. E., Tunnell, N., & Roque, A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_15 · Cited by 96 · see citing works
Personality traits and emotional patterns in irritable bowel syndrome
Muscatello, M. R. A., Bruno, A., Mento, C., Pandolfo, G., & Zoccali, R. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i28.6402 · Cited by 90 · see citing works
Management of the multiple symptoms of irritable bowel syndrome
Simrén, M., Törnblom, H., Palsson, O. S., & Whitehead, W. E. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30116-9 · Cited by 82 · see citing works
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 78 · see citing works
Health-Related Quality of Life in Irritable Bowel Syndrome
Cassar, G. E., Youssef, G., Knowles, S., Moulding, R., & Austin, D. (2020) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000530 · Cited by 27 · see citing works
Common Functional Gastroenterologic Disorders Associated With Abdominal Pain
Bharucha, A., Chakraborty, S., & Sletten, C. (2016) · Mayo Clinic proceedings · doi:10.1016/j.mayocp.2016.06.003 · Cited by 56 · see citing works
Lai, L., Liu, Y., McCracken, L. M., Li, Y., & Ren, Z. (2023) · Behaviour Research and Therapy · doi:10.1016/j.brat.2023.104308 · Cited by 60 · see citing works
Is there a causal link between psychological disorders and functional gastrointestinal disorders?
Koloski, N. A., Holtmann, G., & Talley, N. J. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1801414 · Cited by 65 · see citing works
Rosendahl, J., Alldredge, C. T., & Haddenhorst, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1330238 · Cited by 56 · see citing works
Guidelines on the management of irritable bowel syndrome
Pietrzak, A. M., Skrzydło-Radomańska, B., Mulak, A., Lipiński, M., Malecka-Panas, E. I., Reguła, J., & Rydzewska, G. M. (2018) · Gastroenterology Review · doi:10.5114/pg.2018.78343 · Cited by 56 · see citing works
Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis
Shah, K., Ramos-Garcia, M., Bhavsar, J., & Lehrer, P. M. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103462 · Cited by 55 · see citing works
Benchmarks of Significant Change After Aphasia Rehabilitation
Gilmore, N., Dwyer, M., & Kiran, S. (2019) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2018.08.177 · Cited by 54 · see citing works
Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders
Palsson, O. S., & Ballou, S. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-020-00769-z · Cited by 49 · see citing works
Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition
Song, K. H., Jung, H.-K., Kim, H. J., Koo, H. S., Kwon, Y. H., Shin, H. D., Lim, H. C., Shin, J. E., Kim, S. E., Cho, D. H., et al. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17145 · Cited by 47 · see citing works
“A recent meta-analysis of 41 trials involving 2290 patients reported that psychological therapies reduce gastrointestinal symptoms in patients with IBS at 1-6 months and 6-12 months after treatment.(131) However, these studies had limitations, including a low methodological quality, relatively few patients, and no con…”
BackgroundCognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?
Radziwon, C. D., & Lackner, J. M. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0590-9 · Cited by 42 · see citing works
Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome
Brenner, D. M., Kassebaum-Ladewski, A., & Kinsinger, S. W. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.013 · Cited by 45 · see citing works
Irritable bowel syndrome: diagnosis and management
Masuy, I., Pannemans, J., & Tack, J. F. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02640-0 · Cited by 40 · see citing works
Burton Murray, H., Weeks, I., Becker, K. R., Ljótsson, B., Madva, E. N., Eddy, K. T., Staller, K., Kuo, B., & Thomas, J. J. (2023) · International Journal of Eating Disorders · doi:10.1002/eat.23874 · Cited by 39 · see citing works
Yoga as a Therapy for Irritable Bowel Syndrome
D’Silva, A., MacQUEEN, G. M., Nasser, Y., Taylor, L., Vallance, J. K., & Raman, M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05989-6 · Cited by 39 · see citing works
Psychotherapeutic Interventions in Irritable Bowel Syndrome
Hetterich, L., & Stengel, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00286 · Cited by 37 · see citing works
Wu, X., Wong, C. H. L., Ho, R. S. T., Cheung, W. K. W., Ford, A. C., Wu, J. C. Y., Mak, A. D. P., Cramer, H., & Chung, V. C. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818820438 · Cited by 34 · see citing works
Liu, Y.-W., Wang, Y., Yen, H.-F., Liu, P.-Y., Tzeng, W.-J., Tsai, C.-F., Lin, H., Lee, F., Jeng, O.-J., Lu, C., et al. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09595-w · Cited by 29 · see citing works
Holtmann, G., Schrenk, D., Madisch, A., Allescher, H., Ulrich-Merzenich, G., Mearin, F., Larrey, D., & Malfertheiner, P. (2019) · Digestive Diseases · doi:10.1159/000504570 · Cited by 28 · see citing works
Post-cholecystectomy syndrome and sphincter of Oddi dysfunction: past, present and future
Tarnasky, P. R. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1251308 · Cited by 28 · see citing works
Rawla, P., Sunkara, T., & Raj, J. P. (2018) · Life Science · doi:10.1016/j.lfs.2018.10.001 · Cited by 25 · see citing works
Adults living with irritable bowel syndrome (IBS): A qualitative systematic review
Shorey, S., Demutska, A., Chan, V., & Siah, K. T. H. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110289 · Cited by 28 · see citing works
Biesiekierski, J. R., Manning, L. P., Murray, H. B., Vlaeyen, J. W. S., Ljótsson, B., & Oudenhove, L. V. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17111 · Cited by 27 · see citing works
Sampaio, F., Bonnert, M., Olén, O., Hedman, E., Lalouni, M., Lenhard, F., Ljótsson, B., Ssegonja, R., Serlachius, E., & Feldman, I. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023881 · Cited by 22 · see citing works
Gastrointestinal symptoms following treatment for anorexia nervosa: A systematic literature review
West, M., McMaster, C. M., Staudacher, H. M., Hart, S., Jacka, F. N., Stewart, T., Loughman, A., Rocks, T., & Ruusunen, A. (2021) · International Journal of Eating Disorders · doi:10.1002/eat.23469 · Cited by 25 · see citing works
Torkzadeh, F., Danesh, M., Mirbagher, L., Daghaghzadeh, H., & Emami, M. H. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_464_17 · Cited by 24 · see citing works
Abdelghafar, Y. A., AbdelQadir, Y. H., Motawea, K. R., Nasr, S. A., Omran, H. A. M., Belal, M. M., Elhashash, M. M., AbdelAzim, A. A., & Shah, J. (2022) · Health Science Reports · doi:10.1002/hsr2.814 · Cited by 21 · see citing works
Lee, T.-Y., Hsieh, T., Sung, H., & Chen, W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050708 · Cited by 21 · see citing works
Treating irritable bowel syndrome through an interdisciplinary approach
Nelkowska, D. D. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0441 · Cited by 21 · see citing works
Thakur, E. R., Quigley, B. M., El‐Serag, H. B., Gudleski, G. D., & Lackner, J. M. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.07.006 · Cited by 21 · see citing works
Owusu, J. T., Sibelli, A., Moss-Morris, R. E., van Tilburg, M. A. L., Levy, R. L., & Oser, M. L. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14108 · Cited by 20 · see citing works
Law, M., Pickering, I., Bartlett, E., Sebaratnam, G., Varghese, C., Gharibans, A. A., O’Grady, G., Andrews, C. N., & Calder, S. S. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111516 · Cited by 20 · see citing works
Axelsson, E., Kern, D., Hedman‐Lagerlöf, E., Lindfors, P., Palmgren, J., Hesser, H., Andersson, E., Johansson, R., Olén, O., Bonnert, M., et al. (2023) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2023.2225745 · Cited by 19 · see citing works
Future of Brain–Gut Behavior Therapies: Mediators and Moderators
Burton Murray, H., & Ljótsson, B. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.011 · Cited by 17 · see citing works
Labrenz, F., Spisák, T., Ernst, T., Gomes, C. A., Quick, H. H., Axmacher, N., Elsenbruch, S., & Timmann, D. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113868 · Cited by 19 · see citing works
Mróz, M., Czub, M., & Brytek‐Matera, A. (2022) · Nutrients · doi:10.3390/nu14163447 · Cited by 17 · see citing works
Johannesson, E., Ung, E. J., Sadik, R., & Ringström, G. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1519596 · Cited by 17 · see citing works
Rao, S. S. C., Coss‐Adame, E., Yan, Y., Erdoğan, A., Valestin, J., & Ayyala, D. N. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000381 · Cited by 15 · see citing works
Löwe, B., Nestoriuc, Y., Andresen, V., Vettorazzi, E., Zapf, A., Hübener, S., Maehder, K., Peters, L., & Lohse, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059529 · Cited by 11 · see citing works
Management of irritable bowel syndrome: a narrative review
Tetali, B., & Suresh, S. (2024) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-96 · Cited by 15 · see citing works
Payne, H. (2021) · Innovations in Education and Teaching International · doi:10.1080/14703297.2021.1878052 · Cited by 14 · see citing works
Lackner, J. M. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1780118 · Cited by 15 · see citing works
Hypnotherapy for persons with Irritable Bowel Syndrome: A three-arm randomized controlled trial
Wan, Y.-P., & Ng, S. (2022) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2022.2051424 · Cited by 13 · see citing works
Pathipati, M. P., Scott, L. L., Griser, A. C., & Staller, K. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14811 · Cited by 13 · see citing works
Biobehavioral approach to distinguishing panic symptoms from medical illness
Tunnell, N. C., Corner, S. E., Roque, A. D., Kroll, J. L., Ritz, T., & Meuret, A. E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1296569 · Cited by 15 · see citing works
Diagnosis and treatment of medically unexplained symptoms and chronic functional syndromes.
Clarke, D. D. (2016) · Families Systems & Health · doi:10.1037/fsh0000228 · Cited by 12 · see citing works
Gastrointestinal and Hepatic Disease in Fibromyalgia
Schatz, R. A., & Moshiree, B. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.009 · Cited by 12 · see citing works
Update in diagnosis and management of irritable bowel syndrome
Hung, T.-H., Wang, C.-Y., & Lee, H.-F. (2023) · Tzu-Chi Medical Journal · doi:10.4103/tcmj.tcmj_104_23 · Cited by 15 · see citing works
Die Rolle Der Psychotherapie Beim Reizdarmsyndrom
Weibert, E., & Stengel, A. (2019) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-0829-6990 · Cited by 11 · see citing works
Irritábilisbél-szindróma: komorbid pszichiátriai zavarok és pszichológiai kezelési lehetőségek
Gajdos, P., & Rigó, A. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31247 · Cited by 10 · see citing works
Benzodiazepines’ Role in Managing Gastrointestinal Disorders
Balon, R., Sonino, N., & Rafanelli, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000510686 · Cited by 10 · see citing works
Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial
Laird, K. T., & Stanton, A. L. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101374 · Cited by 10 · see citing works
Self-citationYang, P.-L., Matthews, S. W., Burr, R. L., Cain, K. C., Barney, P., Zia, J. K., Heitkemper, M. M., & Kamp, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053003 · Cited by 10 · see citing works
Holmes, H. J., Thakur, E. R., Carty, J. N., Ziadni, M. S., Doherty, H. K., Lockhart, N. A., Schubiner, H. H., & Lumley, M. A. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.05.002 · Cited by 10 · see citing works
Wallén, H., Ljótsson, B., Svanborg, C., Rydh, S., Falk, L., & Lindfors, P. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2047220 · Cited by 10 · see citing works
Shafiei, F., Dehghani, M., Lavasani, F. F., Manouchehri, M., & Mokhtare, M. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1293150 · Cited by 9 · see citing works
The experiences of physical activity in irritable bowel syndrome—A qualitative study
Johannesson, E., Ung, E. J., Ringström, G., & Sadik, R. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14880 · Cited by 9 · see citing works
Does Yoga Help Patients With Irritable Bowel Syndrome?
Patel, N. K., & Lacy, B. E. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.014 · Cited by 9 · see citing works
Yu, L., Inspector, Y., & McCracken, L. M. (2021) · British Journal of Pain · doi:10.1177/2049463720926559 · Cited by 8 · see citing works
Roles and Impact of Psychologists in Interdisciplinary Gastroenterology Care
Montero, A. M., & Jones, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.067 · Cited by 8 · see citing works
Cognitive-Behavioral Therapy for Irritable Bowel Syndrome
Hunt, M. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-18218-2_5 · Cited by 8 · see citing works
The Role of Virtual Reality in the Management of Irritable Bowel Syndrome
Suchak, K. K., Almario, C. V., Liran, O., Chernoff, R. A., & Spiegel, B. M. R. (2024) · Current Gastroenterology Reports · doi:10.1007/s11894-024-00940-w · Cited by 9 · see citing works
Shahverdi, Z. A., Dehghani, M., Ashouri, A., Manouchehri, M., & Mohebi, N. (2024) · Acta Psychologica · doi:10.1016/j.actpsy.2024.104176 · Cited by 7 · see citing works
Shane, M. S., Ruddy, J., Cline, M. S., Rosenbaum, D. P., Edelstein, S. A., & Moshiree, B. (2024) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s464375 · Cited by 6 · see citing works
Kikuchi, S., Oe, Y., Sasaki, Y., Ishii, H., Ito, Y., Horikoshi, M., Sozu, T., Seno, H., & Furukawa, T. A. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-1157-z · Cited by 6 · see citing works
Hunt, M. G., Dalvie, A., Ipek, S. I., & Wasman, B. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055014 · Cited by 6 · see citing works
Shin, S. Y., Lee, J. Y., Jung, S.-W., Jang, S.-H., Ryu, H. S., Lee, A., Park, G. T., Chang, W., Kim, M., Hwang, B. S., et al. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23161 · Cited by 5 · see citing works
Hunt, M. G., Dalvie, A., Ipek, S. I., Glinski, S., & Macks, R. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002164 · Cited by 5 · see citing works
Ramos, J. M., Rodríguez, A., Sánchez, A., & Mena, A. C. (2018) · Clínica y Salud · doi:10.5093/clysa2018a8 · Cited by 5 · see citing works
Die neue Leitlinie zum Reizdarmsyndrom: Was ändert sich?
von Schassen, H., Andresen, V., & Layer, P. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1331-6478 · Cited by 5 · see citing works
Digital Gut-Directed CBT May Improve Fecal Incontinence in IBS
Varma, S., Scott, L. L., Sibelli, A., Pathipati, M. P., Griser, A. C., & Staller, K. D. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-08871-w · Cited by 4 · see citing works
An Analysis of Six Month Follow-Up Data from a Peer Parent Support Study
Jamison, J., Baker, N., Lopez, M. A., & Bearman, S. K. (2022) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-022-01234-x · Cited by 4 · see citing works
Xie, X., He, J., Xu, S., Xu, Z., Long, Y., Duan, Z., Yang, J., Zhang, Z., Wu, J., Cai, L., et al. (2024) · JGH Open · doi:10.1002/jgh3.13045 · Cited by 4 · see citing works
Mohebbi, Z., Firoozabadi, A., Naini, M. A., Sharif, F., Keshtkaran, Z., & Heydari, N. (2021) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20211014-04 · Cited by 4 · see citing works
Ordí, H. G. (2018) · Clínica y Salud · doi:10.5093/clysa2018a8a · Cited by 5 · see citing works
Hypnosis in the self-regulation of feeling states
Mouheb, Y., Axel Cleeremans, B., Faymonville, M.-É., & Vanhaudenhuyse, A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.08.003 · Cited by 3 · see citing works
Lackner, J. M. (2024) · Pain · doi:10.1097/j.pain.0000000000003186 · Cited by 3 · see citing works
Jandaghı, G., Zia-Tohidi, A., & Firoozi, M. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.71 · Cited by 3 · see citing works
Hunt, M. G. (2022) · Academic Journal of Gastroenterology & Hepatology · doi:10.33552/ajgh.2022.03.000559 · Cited by 2 · see citing works
Extinguishing Fear of Gastrointestinal Symptoms to Treat Functional Gastrointestinal Disorders
Keefer, L. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.004 · Cited by 3 · see citing works
Alam, M., Abbas, K., Khan, M., Saini, R. S., & Faraz, M. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02317-8 · Cited by 2 · see citing works
Potential of a cognitive-behavioural approach to improve patient symptoms in a primary care setting
MacKean, P. (2022) · Canadian Family Physician · doi:10.46747/cfp.680293 · Cited by 2 · see citing works
- Authors
- Laird, K. T., Tanner-Smith, E. E., Russell, A. C., Hollon, S. D., & Walker, L. S.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Laird, Kelsey T.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 14
- Issue
- 7
- Pages
- 937-947.e4
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2215411395
- Semantic Scholar
- 83fd7c8ee686a4fe7eea24cefa1e1f714177bd42
- Cited by
- 135
- References
- 66
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 13 · 2023: 8 · 2022: 19 · 2021: 12 · 2020: 15 · 2019: 20 · 2018: 13 · 2017: 10 · 2016: 10
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Health Professions › Pharmacy › Infant Health and Development
- Keywords
- irritable bowel syndrome, psychotherapy, gastrointestinal symptoms, symptom severity, long-term efficacy, short-term follow-up
- MeSH terms
- Humans, Psychotherapy, Time, Randomized Controlled Trials as Topic, Treatment Outcome, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review